Mark G. Kris, MD

Mark G. Kris, MD, is an attending physician in the Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY. Dr Kris is the first incumbent of the William and Joy Ruane Chair in Thoracic Oncology. Additionally, he is a professor of medicine at Weill Cornell Medical College, also in New York, NY. 

Dr Kris graduated from Fordham University. After receiving his medical degree from Weill Cornell Medical College, he served as chief medical resident and a fellow in medical oncology at MSKCC before joining the attending staff there in 1983.

He is a specialist in lung cancers. Dr Kris is particularly interested in developing ways to choose treatments for patients based on the molecular characteristics of their tumor specimens. His research also includes the evaluation of new anticancer agents (particularly those targeting lung cancers) and multimodality therapy (using surgery, radiation, and drugs together to improve outcomes for individuals with thoracic cancers). 

He is author or coauthor of more than 500 scientific publications. He serves as a member of the Antiemesis Panel for the National Comprehensive Cancer Center Network. Dr Kris also serves as co-chair of the American Society of Clinical Oncology (ASCO) guideline panels for adjuvant chemotherapy and radiation for non–small cell lung cancers and antiemetics. 

Dr Kris is a fellow of the American College of Physicians, the American College of Chest Physicians, and ASCO. He received the first ASCO Humanitarian Award in 2011. He also received the Annie Blount Storrs Award from Calvary Hospital in 2014 and the Willet F. Whitmore Award for Clinical Excellence from MSKCC in 2021. 

*Dr Kris is acting in his personal capacity as author of his articles.